Deep sequencing with longitudinal sampling of a VRC01-like-antibody response in a chronically infected individual by Z Zhang et al.
ORAL PRESENTATION Open Access
Deep sequencing with longitudinal sampling of
a VRC01-like-antibody response in a chronically
infected individual
Z Zhang1*, X Wu2, N Longo2, B Zhang2, J Zhu2, C NISC3, JC Mullikin3, L Wu2, GJ Nabel2, M Connors4, PD Kwong2,
JR Mascola2, L Shapiro1
From AIDS Vaccine 2012
Boston, MA, USA. 9-12 September 2012
Background
VRC01-like antibodies use heavy chain mimicry of the
CD4-receptor to achieve effective neutralization of
HIV-1. The VRC01-like antibodies that have been
observed in a number of HIV-1-infected individuals (i)
display extensive somatic changes (70-100 nucleotide
changes in VH-gene), (ii) can be detected only after sev-
eral years of infection, (iii) derive from VH1-2, and (iv)
are compatible with several different heavy J chains and
different light chains.
Methods
To understand the persistence, evolution, and lineage of
VRC01-like antibodies, we sampled PBMCs from donor
45, the source of VRC01 and VRC03 antibodies, at
approximately yearly intervals over a 15-year period, and
performed deep sequencing on the heavy and light chain
variable portions of expressed antibodies. Anti-idiotypic
antibodies were used to correlate mRNA levels of anti-
bodies identified by the deep sequencing with expressed
levels of these antibodies in serum.
Results
High expression levels of VRC01-like antibody sequences
persisted over the entire 15-year period. Multiple lineages
of VRC01-like antibodies were detected at each time
point, and some of these, in particular the lineages that
include VRC01 and VRC03, persisted over multiple time
points, and displayed extensive branching in their
evolution.
Conclusion
Deep sequencing provides a means to define the genetic
record of the lineage and maturation of antibodies effec-
tive at neutralizing HIV-1. Precise definition of the nat-
ural ontogeny of broadly neutralizing antibodies may be
essential in defining appropriate strategies to elicit such
antibodies in vaccine settings.
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